Please sign in to follow a disease.

Endometrioid epithelial ovarian

Clinical trials for Endometrioid epithelial ovarian explained in plain language.

Never miss a new study

Get alerted when new Endometrioid epithelial ovarian trials appear

Sign up with your email to follow new studies for Endometrioid epithelial ovarian, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

Can a targeted drug duo hold off ovarian cancer's return?

Disease control Not yet recruiting

This trial tests whether raludotatug deruxtecan, given alone or with bevacizumab, can delay cancer growth better than standard care in people with platinum-sensitive ovarian, primary peritoneal, or fallopian tube cancer that has returned after first treatment. About 600 adults as…

Matched conditions: ENDOMETRIOID EPITHELIAL OVARIAN

Phase 3 • Sponsor: Daiichi Sankyo • Aim: Disease control

Last updated Sep 03, 2026 00:00 UTC

Endometrioid epithelial ovarian

Get alerted when new Endometrioid epithelial ovarian trials appear

Can a targeted drug duo hold off ovarian cancer's return?